Futermestotug, CAS 3014361-57-7

Product Description: Futermestotug is a humanized immunoglobulin G1-κ monoclonal antibody targeting human cytotoxic T-lymphocyte associated protein 4 (CTLA4). Futermestotug is promising for research of various malignant tumors[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.

CAS Number: 3014361-57-7

Molecular Weight: N/A

Research Area: Cancer

Target: CTLA-4

• Artikelnummer: MEXHY-P991139-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P991139-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated